Pasternak Andy 4
4 · Horizon Therapeutics Public Ltd Co · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Pasternak Andy
EVP and Chief Business Officer
Transactions
- Tax Payment
Ordinary Shares
2022-12-30$113.80/sh−39,313$4,473,819→ 83,467 total - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−8,709→ 0 total→ Ordinary Shares (8,709 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−5,800→ 0 total→ Ordinary Shares (5,800 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−11,648→ 5,816 total→ Ordinary Shares (11,648 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−14,514→ 0 total→ Ordinary Shares (14,514 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−11,643→ 11,643 total→ Ordinary Shares (11,643 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−26,124→ 0 total→ Ordinary Shares (26,124 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−2,360→ 0 total→ Ordinary Shares (2,360 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−7,935→ 15,870 total→ Ordinary Shares (7,935 underlying) - Exercise/Conversion
Ordinary Shares
2022-12-30+88,733→ 122,780 total
Footnotes (4)
- [F1]Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022.
- [F3]The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024.
- [F4]The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025.